Acro Biomedical (ACBM) Operating Expenses (2015 - 2026)

Acro Biomedical has reported Operating Expenses for 12 years, with the latest figure at $17554.0 in Q2 2026.

• On a quarterly basis, Operating Expenses rose 28.94% year-over-year to $17554.0 in Q2 2026; TTM through Jun 2026 was $162644.0, a 295.52% increase from a year earlier, with the FY2025 full-year figure at $154024.0, up 305.77% from the prior year.
• Operating Expenses was $17554.0 for Q2 2026 at Acro Biomedical, up from $16377.0 in the prior quarter.
• The five-year high for Operating Expenses was $4.0 million in Q3 2022, with the low at $8934.0 in Q1 2025.
• Average Operating Expenses over 5 years is $1.5 million, with a median of $17554.0 recorded in 2026.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses jumped 4530.64% in 2022, then plunged 99.74% in 2024.
• Over 5 years, Operating Expenses stood at $4.0 million in 2022, then plunged by 99.56% to $17401.0 in 2023, then slumped by 45.59% to $9468.0 in 2024, then surged by 72.97% to $16377.0 in 2025, then advanced by 7.19% to $17554.0 in 2026.
• The last three Operating Expenses figures came in at $17554.0 (Q2 2026), $16377.0 (Q4 2025), and $115099.0 (Q3 2025), per Business Quant data.